Benitec Biopharma Inc.
BNTC
$11.50
-$0.18-1.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.30M | -44.02M | -40.11M | -28.69M | -23.61M |
| Total Depreciation and Amortization | 462.00K | 423.00K | 396.00K | 369.00K | 353.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.61M | 23.60M | 18.86M | 5.86M | 3.46M |
| Change in Net Operating Assets | -1.19M | -2.36M | -2.73M | 3.79M | -1.95M |
| Cash from Operations | -18.43M | -22.35M | -23.59M | -18.67M | -21.75M |
| Capital Expenditure | -17.00K | -18.00K | -18.00K | -18.00K | -191.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -17.00K | -18.00K | -18.00K | -18.00K | -191.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 146.84M | 60.22M | 81.87M | 82.57M | 82.57M |
| Repurchase of Common Stock | -9.07M | -9.07M | -9.07M | -9.07M | -39.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.58M | -2.32M | -2.32M | 34.52M | -2.93M |
| Cash from Financing | 129.19M | 48.83M | 70.49M | 108.01M | 79.60M |
| Foreign Exchange rate Adjustments | -187.00K | 230.00K | 49.00K | 164.00K | 300.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.56M | 26.69M | 46.93M | 89.49M | 57.96M |